AusperBio to Present Long-Term Follow-Up Data of AHB-137 Treatment in Chronic Hepatitis B in Two Late-Breaking Oral Presentations at AASLD The Liver Meeting® 2026

ConferenceAHB-137Positive

AI Analysis

Summary

AusperBio announced that two abstracts on long-term follow-up data of AHB-137 for chronic hepatitis B have been selected for late-breaking oral presentations at The Liver Meeting 2026.

Clinical Trial Data

Outcome Details

Long-term follow-up data selected for late-breaking oral presentations

Importance:5/10

Sentiment:

0.50

AHB-137chronic hepatitis Bclinical dataconference presentationAASLD

Read the original article

Published by PR Newswire Biotech on October 8, 2026 12:30 AM

Read Original